Guo Jian, Hong Jiaze, He Yujing, Li Qingyuan, Huang Tongmin, Lou Dandi, Zhang Jie
Intensive Care Unit, The Affiliated Hospital of Ningbo University, LiHuiLi Hospital, Ningbo, Zhejiang, China.
Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Therap Adv Gastroenterol. 2023 Aug 22;16:17562848231192144. doi: 10.1177/17562848231192144. eCollection 2023.
Early fluid resuscitation is one of the main therapeutic strategies for acute pancreatitis (AP). This study investigated the effects of early aggressive and nonaggressive hydration on AP.
The aim of this meta-analysis is to investigate the differences between aggressive and nonaggressive intravenous fluid resuscitation in AP.
This study was based on publicly available data, all of which have been extracted from previous ethically approved studies.
Two authors systematically searched PubMed, Embase (via OVID), Web of Science, and Cochrane Library to find all published research before February 2023. In-hospital mortality were set as primary endpoints.
This meta-analysis included seven randomized controlled trials (RCTs) and eight cohort studies with 4072 individuals in nonaggressive ( = 2419) and aggressive ( = 1653) hydration groups. The results showed that patients in the nonaggressive group had a lower mortality rate than those in the aggressive hydration group [relative risks (RR), 0.66; = 0.02]. Subgroup analysis results showed that patients in the nonaggressive hydration group had lower mortality rates in RCTs (RR, 0.39; = 0.001), studies conducted in Eastern countries (RR, 0.63; = 0.002), and studies with severe pancreatitis (RR, 0.65; = 0.02). In addition, the nonaggressive hydration group had lower rates of infection (RR, 0.62; < 0.001), organ failure (RR, 0.65; = 0.02), and shock (RR, 0.21; = 0.02), as well as a shorter hospital stay (weighted mean difference, -1.63; = 0.001) than the aggressive hydration group.
Early nonaggressive fluid resuscitation is associated with lower mortality, lower risk of organ failure and infection, and shorter hospital stays than aggressive fluid resuscitation.
CRD42023396388.
早期液体复苏是急性胰腺炎(AP)的主要治疗策略之一。本研究调查了早期积极补液和非积极补液对急性胰腺炎的影响。
本荟萃分析的目的是研究急性胰腺炎中积极静脉补液和非积极静脉补液之间的差异。
本研究基于公开可用的数据,所有数据均从先前经伦理批准的研究中提取。
两位作者系统检索了PubMed、Embase(通过OVID)、Web of Science和Cochrane图书馆,以查找2023年2月之前发表的所有研究。将住院死亡率设定为主要终点。
本荟萃分析纳入了7项随机对照试验(RCT)和8项队列研究,共4072例患者,分为非积极补液组(n = 2419)和积极补液组(n = 1653)。结果显示,非积极补液组患者的死亡率低于积极补液组[相对风险(RR),0.66;P = 0.02]。亚组分析结果显示,在RCT中(RR,0.39;P = 0.001)、在东方国家进行的研究中(RR,0.63;P = 0.002)以及在重症胰腺炎研究中(RR,0.65;P = 0.02),非积极补液组患者的死亡率较低。此外,与积极补液组相比,非积极补液组的感染率(RR,0.62;P < 0.001)、器官衰竭率(RR,0.65;P = 0.02)和休克率(RR,0.21;P = 0.02)更低,住院时间更短(加权平均差,-1.63;P = 0.001)。
与积极补液复苏相比,早期非积极补液复苏与更低的死亡率、更低的器官衰竭和感染风险以及更短的住院时间相关。
PROSPERO注册号:CRD42023396388。